Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Has results × Hypersensitivity × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 OTHER 2 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 3 Head and Neck Neoplasms 3 Sarcoma, Kaposi 2 Neoplasm Metastasis 2 Lymphoma, Non-Hodgkin 2 Colonic Neoplasms 2 Uterine Cervical Dysplasia 1 Ulcer 1 Tongue Neoplasms 1 Stomatitis 1 Skin Neoplasms 1 Shoulder Injuries 1 Shoulder Dislocation 1 Salivary Gland Neoplasms 1 Salivary Gland Adenoma, Pleomorphic 1 Radiodermatitis 1 Radiation Injuries 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Parasomnias 1 Papillomavirus Infections 1 Meningococcal Infections 1 Melanoma 1 Margins of Excision 1 Lymphoma 1 Lymphedema 1 Lung Neoplasms 1 Kidney Transplantation 1 Joint Instability 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02835625 2024-08-28

TOBE

Norwegian Institute of Public Health

Phase NA Completed

29,453 enrolled 15 charts

Breast Neoplasms, Hypersensitivity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡